CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleRevenue is $982.58M, above the global median of $548.88M
- PositionPrice-to-book is 0.83×, lower than 95% of its Medical Instruments & Supplies peers (median 2.75×)
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
5.89BCNY878.85M · vs all stocks (USD)
Revenue (TTM)
6.59BCNY982.58M · vs all stocks (USD)
Profit Margin
-8.25%vs Medical Instruments & Supplies peers
Beta
0.0760xvs all stocks
52-Week Change
2.63%vs all stocks
Market Capitalization
5.89BCNY878.85M · vs all stocks (USD)
Enterprise Value
9.88BCNY1.47B · vs all stocks (USD)
Forward P/E
28.14xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
0.9036xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
0.8306xvs Medical Instruments & Supplies peers
Enterprise to Revenue
1.50xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
12.19xvs Medical Instruments & Supplies peers
Gross Margin
33.40%vs Medical Instruments & Supplies peers
Profit Margin
-8.25%vs Medical Instruments & Supplies peers
Operating Margin
17.18%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
1.04%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
-4.90%vs Medical Instruments & Supplies peers
Revenue (TTM)
6.59BCNY982.58M · vs all stocks (USD)
Revenue per Share (TTM)
6.74CNYUpdated Sep 19, 2026Quarterly Revenue Growth
56.50%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
1.52BCNY226.68M · vs all stocks (USD)
EBITDA (TTM)
382.85MCNY57.11M · vs all stocks (USD)
Net Income (TTM)
-543.25MCNY-81.03M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
40.77%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
526.56MCNY78.54M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
839.73MCNY125.25M · vs all stocks (USD)
5-Year Average Dividend Yield
0.92%vs all stocks
Payout Ratio
0.00%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
2.30BCNYFY2025 · Dec 31, 2025Revenue
5.74BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
4.84BCNYFY2025 · Dec 31, 2025Gross Profit
899.28MCNYFY2025 · Dec 31, 2025Operating Income
-168.92MCNY-25.20M · vs all stocks (USD)
Pre-tax Income
-661.14MCNYFY2025 · Dec 31, 2025Income Tax Expense
137.28MCNYFY2025 · Dec 31, 2025Net Income
-798.41MCNYFY2025 · Dec 31, 2025EBIT
-389.07MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
382.85MCNYFY2025 · Dec 31, 2025Research & Development
254.42MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
327.80MCNYFY2025 · Dec 31, 2025Other Operating Expenses
52.26MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
24.72MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
272.07MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.7600CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.7600CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
998.61MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
998.61MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-798.41MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
39.47MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-419.61MCNYFY2025 · Dec 31, 2025Free Cash Flow
-970.02MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.62BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-798.41MCNYFY2025 · Dec 31, 2025Other Non-cash Items
249.53MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
194.15MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-64.87MCNYFY2025 · Dec 31, 2025Capital Expenditures
-550.41MCNYFY2025 · Dec 31, 2025Net Acquisitions
-228.76MCNYFY2025 · Dec 31, 2025Purchase of Investments
-603.13MCNYFY2025 · Dec 31, 2025Sale of Investments
117.93MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-1.26BCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
878.00MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-882.84MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-168.38MCNYFY2025 · Dec 31, 2025Other Financing Charges
711.54MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
538.32MCNYFY2025 · Dec 31, 2025Shares Outstanding
1.01BSharesUpdated Sep 19, 2026Float Shares
697.96MSharesUpdated Sep 19, 2026% Held by Insiders
32.34%vs all stocks
% Held by Institutions
3.85%vs all stocks
Total Cash (MRQ)
1.57BCNY234.49M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.57CNYUpdated Sep 19, 2026Total Debt (MRQ)
3.19BCNY476.13M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.3356xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
0.9090xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
7.12CNYUpdated Sep 19, 2026Total Assets
16.76BCNY2.50B · vs all stocks (USD)
Total Current Assets
5.51BCNYFY2025 · Dec 31, 2025Total Liabilities
7.30BCNYFY2025 · Dec 31, 2025Total Non-current Assets
11.26BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
826.79MCNYFY2025 · Dec 31, 2025Total Current Liabilities
6.47BCNYFY2025 · Dec 31, 2025Cash
1.62BCNYFY2025 · Dec 31, 2025Cash Equivalents
80.12MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.70BCNYFY2025 · Dec 31, 2025Other Short-term Investments
934.03MCNYFY2025 · Dec 31, 2025Accounts Receivable
1.08BCNYFY2025 · Dec 31, 2025Inventory
1.13BCNYFY2025 · Dec 31, 2025Accounts Payable
480.45MCNYFY2025 · Dec 31, 2025Short-term Debt
4.54BCNYFY2025 · Dec 31, 2025Other Current Liabilities
1.38MCNYFY2025 · Dec 31, 2025Long-term Debt
626.49MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
14.49MCNYFY2025 · Dec 31, 2025Common Stock (Book)
1.01BCNYFY2025 · Dec 31, 2025Retained Earnings
849.20MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
9.46BCNY1.41B · vs all stocks (USD)
Treasury Stock
30.00MCNYFY2025 · Dec 31, 202552-Week Low
5.00CNYUpdated Sep 19, 202652-Week High
8.91CNYUpdated Sep 19, 202652-Week Change
2.63%vs all stocks
Beta
0.0760xvs all stocks
50-Day MA
5.84CNYUpdated Sep 19, 2026200-Day MA
6.26CNYUpdated Sep 19, 2026Avg 10-Day Volume
8.45MSharesUpdated Sep 19, 2026Avg 30-Day Volume
11.89MSharesUpdated Sep 19, 2026Diluted EPS (TTM)
-0.5400CNYUpdated Sep 19, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Price-to-book is 0.83×, lower than 95% of its Medical Instruments & Supplies peers (median 2.75×)Notable
Price-to-book: 0.83Industry median: 2.75Industry P5: 0.85Peers compared: 62.00
Financial Health
Altman Z-Score 0.75: distress zoneCritical
Altman Z-Score: 0.75
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Revenue is $982.58M, above the global median of $548.88MNotable
Revenue (USD): 982,580,278.395Global Median: 548,883,780.48
Levered free cash flow is $125.25M, above the global median of $18.73MNotable
Levered free cash flow (USD): 125,254,200.783Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Grieg Seafood ASA
Tier 1ProductionThroughput-Bound ConversionFlowRule
Clevo Co.
Tier 1ProductionThroughput-Bound ConversionFlowInterface
Wuhan Zhongyuan Huadian Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Beijing Unistrong Science & Technology Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Beijing Bayi Space LCD Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Hangzhou Star Shuaier Electric Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Fujian Longxi Bearing (Group) Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Zhejiang Jw Precision Machinery Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
China West Construction Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Nanjing Redsun Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow